Targeting Bcl-2 with oblimersen for patients with hormone refractory prostate cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://link.springer.com/content/pdf/10.1007/s00345-004-0477-x.pdf
Reference40 articles.
1. Saad F, Gleason DM, Murray R et al. (2004) Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst 96:879?882
2. Tannock IF, Osoba D, Stockler MR et al. (1996) Chemotherapy with plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. J Clin Oncol 14:1756?1764
3. Kantoff PW, Halabi S, Conaway M et al. (1999) Hydrocortisone with or without in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study. J Clin Oncol 17:2506?2513
4. Beer TM, Pierce WC, Lowe BA et al. (2001) Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer. Ann Oncol 12:1273?1279
5. Petrylak DP, Tangen CM, Hussain MHA et al. (2004) Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. New Engl J Med 315:1513?1520
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synergistic effect of chimeric antigen receptor modified with Bcl-2 on enhanced solid tumour targeting;Human Cell;2024-06-15
2. Phosphoprotein phosphatase 1-interacting proteins as therapeutic targets in prostate cancer;World Journal of Pharmacology;2014
3. Bcl-2 Family of Proteins as Therapeutic Targets in Genitourinary Neoplasms;Clinical Genitourinary Cancer;2013-03
4. Vitamin D3 cryosensitization increases prostate cancer susceptibility to cryoablation via mitochondrial-mediated apoptosis and necrosis;BJU International;2011-08-26
5. Targets for molecular therapy in esophageal squamous cell carcinoma: an immunohistochemical analysis;Diseases of the Esophagus;2009-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3